CLLS
CellectisANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
12
U.S. public peers
Grade Position
Above peers
vs peer average
CLLS vs peer average
89/100
CLLS vs. peer average (A vs. C)
Grade spread
A 1 · B 2 · C 2 · D 5 · F 2
Graded peers loaded
Coverage
12 graded
100% of tracked
Peer overview
ALLO is the first available peer comparator.
Allogene — allogeneic CAR-T peer; comparable manufacturing and scale risks, useful commercialization comparator.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CLLS
Cellectis
ALLO
Allogene Therapeutics
Grade
A
A
Momentum
95
96
Value
44
41
Sentiment
68
58
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ALLO
CLLS / ALLO
Grade Position
Above peers
CLLS vs. peer average (A vs. C)
89/100
Momentum
95
ALLOValue
44
CLLSSentiment
68
CLLSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CLLS
ALLO is the first peer returned for this comparison set.